Abstract
Over the past decade, nanomedicine and nanobiology have undergone radical transformations from fantasy to real science. The days of discussing advances in this area in the context of “nanobots” are over, and systems and nanomaterials have emerged that provide major analytical or therapeutic advantages over conventional molecule-based structures and approaches. We have come to recognize that much of biology is executed at the nanoscale level, therefore providing a rational approach to using the structure and function of engineered nanomaterials at the nano-bio interface for interrogation of disease, diagnosis, treatment, and imaging at levels of sophistication not possible before [1]. Fabrication of a host of nanostructures has been coupled with advanced chemical manipulation in order to impart biological recognition and interaction capabilities. Often, chemical manipulation results in nanomaterials that provide performance enhancement of therapeutics, imaging agents, diagnostics, and materials for tissue engineering and for basic science applications.
* With contributions from: Barbara A. Baird, Carl Batt, David Grainger, Sanjiv Sam Gambhir, Demir Akin, Otto Zhou, J. Fraser Stoddart, Thomas J. Meade, Piotr Grodzinski, Dorothy Farrell, Harry F. Tibbals, Joseph De Simone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
PSA is a serum biomarker used to screen individuals for prostate cancer and also as a marker for prostate cancer recurrence following primary and secondary prostate cancer intervention [32].
References
A.E. Nel, L. Madler, D. Velegol, T. Xia, E.M.V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, M. Thompson, Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543–557 (2009). doi:10.1038/nmat2442
European Science Foundation (ESF), Nanomedicine: An ESF – European Medical Research Council Forward Look Report (ESF, Strasbourg, France, 2005), Available online: http://www.esf.org/publications/forward-looks.html
A. Nel, T. Xia, L. Madler, N. Li, Toxic potential of materials at the nanolevel. Science 311(5761), 622–627 (2006). doi:10.1126/science.1114397
P. Grodzinski, M. Silver, L.K. Molnar, Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev. Mol. Diagn. 6(3), 307–318 (2006)
F. Alexis, E.M. Pridgen, R. Langer, O.C. Farokhzad, Nanoparticle technologies for cancer therapy. Handb. Exp. Pharmacol. 197, 55–86 (2010)
S.X. Tang, J. Zhao, J.J. Storhoff, P.J. Norris, R.F. Little, R. Yarchoan, S.L. Stramer, T. Patno, M. Domanus, A. Dhar, C. Mirkin, I.K. Hewlett, Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J. Acquir. Immune Defic. Syndr. 46(2), 231–237 (2007). doi:10.1097/QAI.0b013e31814a554b
M.E. Davis, J.E. Zuckerman, C.H. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291), 1067–1070 (2010). doi:10.1038/nature08956
A.E. Prigodich, D.S. Seferos, M.D. Massich, D.A. Giljohann, B.C. Lane, C.A. Mirkin, Nano-flares for mRNA regulation and detection. ACS Nano 3(8), 2147–2152 (2009). doi:10.1021/nn9003814
D.S. Seferos, D.A. Giljohann, H.D. Hill, A.E. Prigodich, C.A. Mirkin, Nano-flares: probes for transfection and mRNA detection in living cells. J. Am. Chem. Soc. 129(50), 15477–15479 (2007). doi:10.1021/ja0776529
D. Zheng, D.S. Seferos, D.A. Giljohann, P.C. Patel, C.A. Mirkin, Aptamer nano-flares for molecular detection in living cells. Nano Lett. 9(9), 3258–3261 (2009). doi:10.1021/nl901517b
A. De la Zerda, C. Zavaleta, S. Keren, S. Vaithilingham, S. Bodapati, Z. liu, J. Levi, B.R. Smith, T. Ma, O. Oralkan, Z. Cheng, X. Chen, H. Dai, B.T. Kuri-Yakub, S.S. Gambhir, Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 3(9), 557–562 (2008). doi:10.1038/nnano.2008.231
S. Keren, C. Zavaleta, Z. Cheng, A. de la Zerda, O. Gheysens, S.S. Gambhir, Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 105(15), 5844–5849 (2008). doi:10.1073/pnas.0710575105
J.L. Major, T.J. Meade, Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc. Chem. Res. 42(7), 893–903 (2009). doi:10.1021/ar800245h
Y. Song, X. Xu, K.W. MacRenaris, X.Q. Zhang, C.A. Mirkin, T.J. Meade, Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew. Chem. Int. Ed Engl. 48(48), 9143–9147 (2009)
C. Zavaleta, A. de la Zerda, Z. Liu, S. Keren, Z. Cheng, M. Schipper, X. Chen, H. Dai, S.S. Gambhir, Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett. 8(9), 2800–805 (2008). Available online: http://www.adelazerda.com/NanoLetters_08.pdf
S. George, S. Pokhrel, T. Xia, B. Gilbert, Z. Ji, M. Schowalter, A. Rosenauer, R. Damoiseaux, K.A. Bradley, L. Madler, A.E. Nel, Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 4(1), 15–29 (2010)
M. Liong, J. Lu, M. Kovochich, T. Xia, S.G. Ruehm, A.E. Nel, F. Tamanoi, J.I. Zink, Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5), 889–896 (2008). doi:10.1021/nn800072t
J. Lu, M. Liong, S. Sherman, T. Xia, M. Kovochich, A. Nel, J. Zink, F. Tamanoi, Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. Nanobiotechnology 3(3), 89–95 (2007). doi:10.1007/s12030-008-9003-3
J. Lu, M. Liong, Z. Li, J.I. Zink, F. Tamanoi, Biocompatability, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16), 1794–1805 (2010)
H. Meng, M. Liong, T. Xia, Z. Li, Z. Ji, J.I. Link, A.E. Nel, Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and Pgp siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4(8), 4539–4550 (2010). doi:10.1021/nn100690m
H. Meng, M. Xie, T. Xia, Y. Zhao, F. Tamanoi, J.F. Stoddart, J.I. Zink, A. Nel, Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J. Am. Chem. Soc. 132(36), 12690–12697 (2010). doi:10.1021/ja104501a
T. Xia, M. Kovochich, M. Liong, H. Meng, S. Kabahie, S. george, J.I. Zink, A. Nel, Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3(10), 3273–3286 (2009)
D.G. Georganopoulou, L. Chang, J.W. Nam, C.S. Thaxton, E.J. Mufson, W.L. Klein, C.A. Mirkin, Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease. Proc. Natl. Acad. Sci. U. S. A. 102(7), 2273–2276 (2004). doi:10.1073/pnas.0409336102
C.A. Mirkin, C.S. Thaxton, N.L. Rosi, Nanostructures in biodefense and molecular diagnostics. Expert Rev. Mol. Diagn. 4(6), 749–751 (2004)
J.M. Nam, S.I. Stoeva, C.A. Mirkin, Bio-bar-code-based DNA detection with PCR-like sensitivity. J. Am. Chem. Soc. 126(19), 5932–5933 (2004). doi:10.1021/ja049384+
J.M. Nam, C.S. Thaxton, C.A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301(5641), 1884–1886 (2003). doi:10.1126/science.1088755
S.I. Stoeva, J.S. Lee, C.S. Thaxton, C.A. Mirkin, Multiplexed DNA detection with biobarcoded nanoparticle probes. Angew. Chem. Int. Ed Engl. 45(20), 3303–3306 (2006). doi:10.1002/anie.200600124
C.S. Thaxton, H.D. Hill, D.G. Georganopoulou, S.I. Stoeva, C.A. Mirkin, A bio-bar-code assay based upon dithiothreitol-induced oligonucleotide release. Anal. Chem. 77(24), 8174–8178 (2005)
C.S. Thaxton, N.L. Rosi, C.A. Mirkin, Optically and chemically encoded nanoparticle materials for DNA and protein detection. MRS Bull. 30(5), 376–380 (2005)
D. Kim, W.L. Daniel, C.A. Mirkin, Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probes. Anal. Chem. 81(21), 9183–9187 (2009). doi:10.1021/ac9018389
T.A. Taton, C.A. Mirkin, R.L. Letsinger, Scanometric DNA array detection with nanoparticle probes. Science 289(5485), 1757–1760 (2000). doi:10.1126/science.289.5485.1757
C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, P.C. Walsh, Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17), 1591–1597 (1999)
G.L. Andriole, R.L. Grubb III, S.S. Buys, D. Chia, T.R. Church, M.N. Fouad, E.P. Gelmann, P.A. Kvale, D.J. Reding, J.L. Weissfeld, L.A. Yokochi, E.D. Crawford, B. O’Brien, J.D. Clapp, J.M. Rathmell, T.L. Riley, R.B. Hayes, B.S. Kramer, G. Izmirlian, A.B. Miller, P.F. Pinsky, P.C. Prorok, J.K. Gohagan, C.D. Berg, Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360(13), 1310–1319 (2009)
F.H. Schroder, J. Hugosson, M.J. Roobol, T.L.J. Tammela, S. Ciatto, V. Nelen, M. Kwiatkowski, M. Lujan, H. Lilja, M. Zappa, L.J. Denis, F. Recker, A. Berenguer, L. Määttänen, C.H. Bangma, G. Aus, A. Villers, X. Rebillard, T. van der Kwast, B.G. Blijenberg, S.M. Moss, H.J. de Koning, A. Auvinen, ERSPC Investigators, Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360(13), 1320–1328 (2009)
W.J. Catalona, D.S. Smith, 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol. 152(5), 1837–1842 (1994)
T.L. Jang, M. Han, K.A. Roehl, S.A. Hawkins, W.J. Catalona, More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects. Urology 67(2), 343–348 (2006). doi:10.1016/j.urology.2005.08.048
J.G. Trapasso, J.B. deKernion, R.B. Smith, F. Dorey, The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J. Urol. 152(5), 1821–1825 (1994)
B.J. Trock, M. Han, S.J. Freedland, E.B. Humphreys, T.L. DeWeese, A.W. Partin, P.C. Walsh, Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299(23), 2760–2769 (2008)
H. Yu, E.P. Diamandis, A.F. Prestigiacomo, T.A. Stamey, Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Clin. Chem. 41(3), 430–434 (1995)
C.S. Thaxton, R. Elghanian, A.D. Thomas, S.I. Stoeva, J.S. Lee, N.D. Smith, A.J. Schaeffer, H. Klocker, W. Horninger, G. Bartsch, C.A. Mirkin, Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy. Proc. Natl. Acad. Sci. U. S. A. 106(44), 18437–18442 (2009). doi:10.1073/pnas.0904719106
A.K. Lytton-Jean, C.A. Mirkin, A thermodynamic investigation into the binding properties of DNA functionalized gold nanoparticle probes and molecular fluorophore probes. J. Am. Chem. Soc. 127(37), 12754–12755 (2005)
R. Elghanian, J.J. Storhoff, R.C. Mucic, R.L. Letsinger, C.A. Mirkin, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277(5329), 1078–1081 (1997). doi:10.1126/science.277.5329.1078
J.J. Storhoff, A.D. Lucas, V. Garimella, Y.P. Bao, U.R. Muller, Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat. Biotechnol. 22(7), 883–887 (2004)
J.J. Storhoff, S.S. Marla, P. Bao, S. Hagenow, H. Mehta, A. Lucas, V. Garimella, T. Patno, W. Buckingham, W. Cork, U.R. Muller, Gold nanoparticle-based detection of genomic DNA targets on microarrays using a novel optical detection system. Biosens. Bioelectron. 19(8), 875–883 (2004). doi:10.1016/j.bios.2003.08.014
D.A. Giljohann, D.S. Seferos, A.E. Prigodich, P.C. Patel, C.A. Mirkin, Gene regulation with polyvalent siRNA-nanoparticle conjugates. J. Am. Chem. Soc. 131(6), 2072–2073 (2009). doi:10.1021/ja808719p
N.L. Rosi, D.A. Giljohann, C.S. Thaxton, A.K.R. Lytton-Jean, M.S. Han, C.A. Mirkin, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312(5776), 1027–1030 (2006). doi:10.1126/science.1125559
D.S. Seferos, A.E. Prigodich, D.A. Giljohann, P.C. Patel, C.A. Mirkin, Polyvalent DNA nanoparticle conjugates stabilize nucleic acids. Nano Lett. 9(1), 308–311 (2009). doi:10.1021/nl802958f
D.S. Seferos, D.A. Giljohann, N.L. Rosi, C.A. Mirkin, Locked nucleic acid-nanoparticle conjugates. Chem. Biochem 8(11), 1230–1232 (2007). doi:10.1002/cbic.200700262
N. Nerambourg, R. Praho, M.H.V. Werts, D. Thomas, M. Blanchard-Desce, Hydrophilic monolayer-protected gold nanoparticles and their functionalisation with fluorescent chromophores. Int. J. Nanotechnol. 5(6–8), 722–740 (2008). doi:10.1504/IJNT.2008.018693
T. Meade, Seeing is believing. Acad. Radiol. 8(1), 1–3 (2001)
D. Neuberger, J. Wong, Suspension for intravenous injection: image analysis of scanning electron micrographs of particles to determine size and volume. PDA J. Pharm. Sci. Technol. 59(3), 187–199 (2005)
L.M. Manus, D.J. Mastarone, E.A. Waters, X.-Q. Zhang, E.A. Schultz-Sikma, K.W. MacRenaris, D. Ho, T.J. Meade, Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett. 10(2), 484–489 (2010). doi:10.1021/nl903264h
C.L. Zavaleta, B.R. Smith, I. Walton, W. Doering, G. Davis, B. Shojaei, M.J. Natan, S.S. Gambhir, Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 106(32), 13511–13516 (2009). doi:10.1073/pnas.0813327106
S.M. van de Ven, N. Mincu, J. Brunette, G. Ma, M. Khayat, D.M. Ikeda, S.S. Gambhir, Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system–a phantom study. Department of Radiology, Stanford University Medical Center, Stanford, CA, USA. Mol Imaging Biol. Apr;13(2):232–238 (2011)
M.E. Davis, The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 6(3), 659–668 (2009). doi:10.1021/mp900015y
D.W. Bartlett, M.E. Davis, Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug. Chem. 18(2), 456–468 (2007). doi:10.1021/bc0603539
S.H. Pun, N.C. Bellocq, A. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. Wen, H. Engler, J. Heidel, M.E. Davis, Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug. Chem. 15(4), 831–840 (2004). doi:10.1021/bc049891g
D.J. Heidel, J.D. Heidel, J. Yi-Ching Liu, Y. Yen, B. Zhou, B.S.E. Heale, J.J. Rossi, D.W. Bartlett, M.E. Davis, Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo. Clin. Cancer Res. 13(7), 2207–2215 (2007). doi:10.1158/1078-0432.CCR-06-2218
D.J. Heidel, Z. Yu, J. Yi-Ching Liu, S.M. Rele, Y. Liang, R.K. Zeidan, D.J. Kornbrust, M.E. Davis, Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. U. S. A. 104(14), 5715–5721 (2007). doi:10.1073/pnas.0701458104
S. Hu-Lieskovan, J.D. Heidel, D.W. Bartlett, M.W. Davis, T.J. Triche, Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma. Cancer Res. 65(19), 8984–8992 (2005). doi:10.1158/0008-5472.CAN-05-0565
D.W. Bartlett, H. Su, I.J. Hildebrandt, W.A. Weber, M.E. Davis, Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. U. S. A. 104(39), 15549–15554 (2007). doi:10.1073/pnas.0707461104
D.W. Bartlett, M.E. Davis, Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng. 99(4), 975–85 (2008). doi:10.1002/bit.21668
L.M. Demers, C.A. Mirkin, R.C. Mucic, R.A. Reynolds III, R.L. Letsinger, R. Elghanian, G. Viswanadham, A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. Anal. Chem. 72(22), 5535–5541 (2000)
D.A. Giljohann, D.S. Seferos, P.C. Patel, J.E. Millstone, N.L. Rosi, C.A. Mirkin, Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 7(12), 3818–3821 (2007)
C.A. Mirkin, R.L. Letsinger, R.C. Mucic, J.J. Storhoff, A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382(6592), 607–609 (1996). doi:10.1038/382607a0
I. Lebedeva, C.A. Stein, Antisense oligonucleotides: promise and reality. Annu. Rev. Pharmacol. Toxicol. 41, 403–419 (2001)
G.S. Getz, C.A. Reardon, Nutrition and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 27(12), 2499–2506 (2007)
R. Josi, S. Jan, Y. Wu, S. MacMahon, Global inequalities in access to cardiovascular health care. J. Am. Coll. Cardiol. 52(23), 1817–1825 (2008)
A.J. Lusis, Atherosclerosis. Nature 407(6801), 233–241 (2000)
L.G. Spagnoli, E. Bonanno, G. Sangiorgi, A. Mauriello, Role of inflammation in atherosclerosis. J. Nucl. Med. 48(11), 1800–1815 (2007). doi:10.2967/jnumed.107.038661
W.B. Kannel, W.P. Castelli, T. Gordon, P.M. McNamara, Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study. Ann. Intern. Med. 74(1), 1–12 (1971)
W.B. Kannel, P.W.F. Wilson, An update on coronary risk factors. Med. Clin. North Am. 79(5), 951–971 (1995)
T.C. Andrews, K. Raby, J. Barry, C.L. Naimi, E. Allred, P. Ganz, A.P. Selwyn, Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 95(2), 324–328 (1997)
C.M. Ballantyne, J.A. Herd, J.K. Dunn, P.H. Jones, J.A. Farmer, A.M. Gotto Jr., Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr. Opin. Lipidol. 8(6), 354–361 (1997)
A. Zambon, J.E. Hokanson, Lipoprotein classes and coronary disease regression. Curr. Opin. Lipidol. 9(4), 329–336 (1998)
H.B. Brewer, Increasing HDL cholesterol levels. N. Engl. J. Med. 350(15), 1491–1494 (2004)
E.M. Degoma, R.L. Degoma, D.J. Rader, Beyond high-density lipoprotein cholesterol levels: evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol. 51(23), 2199–2211 (2008)
T. Joy, R.A. Hegele, Is raising HDL a futile strategy for atheroprotection? Nat. Rev. Drug Discovery 7(2), 143–155 (2008)
P. Conca, G. Franceschini, Synthetic HDL as a new treatment for atherosclerosis regression: has the time come? Nutr. Metab. Cardiovasc. Dis. 18(4), 329–335 (2008)
A. Kontush, M.J. Chapman, Antiatherogenic small, dense HDL – guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 3(3), 144–153 (2006). doi:10.1038/ncpcardio0500
I.M. Singh, M.H. Shishehbor, B.J. Ansell, High-density lipoprotein as a therapeutic target – A systematic review. JAMA 298(7), 786–798 (2007)
G.F. Watts, P.H.R. Barrett, D.C. Chan, HDL metabolism in context: looking on the bright side. Curr. Opin. Lipidol. 19(4), 395–404 (2008)
C.S. Thaxton, W.L. Daniel, D.A. Giljohann, A.D. Thomas, C.A. Mirkin, Templated spherical high density lipoprotein nanoparticles. J. Am. Chem. Soc. 131(4), 1384–1385 (2009). doi:10.1021/ja808856z
Y. Klichko, M. Liong, E. Choi, S. Angelos, A.E. Nel, J.F. Stoddart, F. Tamanoi, J.I. Zink, Mesostructured silica for optical functionality, nanomachines, and drug delivery. J. Am. Ceram. Soc. 92(s1), s2–s10 (2009). doi:10.1111/j.1551-2916.2008.02722.x
S. Saha, E. Johansson, A.H. Flood, H.-R. Tseng, J.I. Zink, J.F. Stoddart, A photoactive molecular triad as a nanoscale power supply for a supramolecular machine. Chemistry 11(23), 6846–6858 (2005). doi:10.1002/ chem.200500371
S. Angelos, Y.W. Yang, K. Patel, J.F. Stoddart, J.I. Zink, pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. Angew. Chem. Weinheim. Bergstr. Ger. 47(12), 2222–2226 (2008). doi:10.1002/anie.200705211
N.M. Khashab, M.E. Belowich, A. Trabolsi, D.C. Friedman, C. Valente, Y. Lau, H.A. Khatib, J.I. Zink, J.F. Stoddart, pH-responsive mechanised nanoparticles gated by semirotaxanes. Chem. Commun. Camb. 36, 5371–5373 (2009). doi:10.1039/B910431C
K. Patel, S. Angelos, W.R. Dichtel, A. Coskun, Y.-W. Yang, J.I. Zink, J.F. Stoddart, Enzyme-responsive snap-top covered silica nanocontainers. J. Am. Chem. Soc. 130(8), 2382–2383 (2008). doi:10.1021/ja0772086
S.E. Gratton, S.S. Williams, M.E. Napier, P.D. Pohlhaus, Z. Zhou, K.B. Wiles, B.W. Maynor, C. Shen, T. Olafsen, E.T. Samulski, J.M. DeSimone, he pursuit of a scalable nanofabrication platform for use in material and life science applications. Acc. Chem. Res. 41(12), 1685–1695 (2008). doi:10.1021/ar8000348
L.E. Euluss, J.A. DuPont, S. Gratton, J. DeSimone, Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 35(11), 1095–1104 (2006). doi:10.1039/B600913C
R.A. Petros, P.A. Ropp, J.M. DeSimone, Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells. J. Am. Chem. Soc. 130(15), 5008–5009 (2008)
I. Elloumi-Hannachi, M. Yamato, T. Okano, Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J. Intern. Med. 267(1), 54–70 (2010)
T. Shimizu, H. Sekine, M. Yamato, T. Okano, Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr. Pharm. Des. 15(24), 2807–2814 (2009)
S. Masuda, T. Shimizu, M. Yamato, T. Okano, Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 60, 277–285 (2008)
C.S. Chen, M. Mrksich, S. Huang, G.M. Whitesides, D.E. Ingber, Micropatterned surfaces for control of cell shape, position, and function. Biotechnol. Prog. 14(3), 356–363 (1998). doi:10.1021/bp980031m
J. James, E.D. Goluch, H. Hu, C. Liu, M. Mrksich, ubcellular curvature at the perimeter of micropatterned cells influences lamellipodial distribution and cell polarity. Cell Motil. Cytoskeleton 65(11), 841–852 (2008). Available online: http://www.mech.northwestern.edu/medx/web/publications/papers/196.pdf
M. Mrksich, C.S. Chen, Y. Xia, L.E. Dike, D.E. Ingber, G.M. Whitesides, Controlling cell attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold. Proc. Natl. Acad. Sci. U. S. A. 93(20), 10775–10778 (1996)
M. Mrksich, L.E. Dike, J. Tien, D.E. Ingber, G.M. Whitesides, Using microcontact printing to pattern the attachment of mammalian cells to self-assembled monolayers of alkanethiolates on transparent films of gold and silver. Exp. Cell Res. 235(2), 305–313 (1997)
M. Mrksich, G.M. Whitesides, Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells. Annu. Rev. Biophys. Biomol. Struct. 25, 55–78 (1996)
S. Heydarkhan-Hagvall, C.H. Choi, J. Dunn, S. Heydarkhan, K. Schenke-Layland, W.R. MacLellan, R.E. Beygui, Influence of systematically varied nano-scale topography on cell morphology and adhesion. Cell Commun. Adhes. 14(5), 181–194 (2007)
J.H. Silver, J.C. Lin, F. Lim, V.A. Tegoulia, M.K. Chaudhury, S.L. Cooper, Surface properties and hemocompatibility of alkyl-siloxane monolayers supported on silicone rubber: effect of alkyl chain length and ionic functionality. Biomaterials 20(17), 1533–1543 (1999). doi:10.1016/S0142-9612(98)00173-2
A.J. Torres, L. Vasudevan, D. Holowka, B.A. Baird, Focal adhesion proteins connect IgE receptors to the cytoskeleton as revealed by micropatterned ligand arrays. Proc. Natl. Acad. Sci. U. S. A. 105(45), 17238–17244 (2008). doi:10.1073/pnas.0802138105
D.W. Hobson, Commercialization of nanotechnology Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(2), 189–202 (2009). doi:10.1002/wnan.28
J. Shendure, R.D. Mitra, C. Varma, G.M. Church, Advanced sequencing technologies: methods and goals. Nat. Rev. Genet. 5(5), 335–344 (2004). doi:10.1038/nrg1325
D. Gibson, G.A. Benders, C. Andrews-Pfannkoch, E.A. Denisova, H. Baden-Tillson, J. Zaveri, T.B. Stockwell, A. Brownley, D.W. Thomas, M.A. Algire, C. Merryman, L. Young, V.N. Noskov, J.I. Glass, J.C. Venter, C.A. Hutchison III, H.O. Smith, Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Sci. Signal. 319(5867), 1215–1220 (2008)
C. Noren, S. Anthony-Cahill, M. Griffith, P. Schultz, A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244(4901), 182–188 (1989). doi:10.1126/science.2649980
C. Gauchet, G. Labadie, C. Poulter, Regio- and chemoselective covalent immobilization of proteins through unnatural amino acids. J. Am. Chem. Soc. 128(29), 9274–9275 (2006)
R. Baum, Drexler and Smalley make the case for and against ‘molecular assemblers. Chem. Eng. News 81(48), 37–42 (2003). Available online: http://pubs.acs.org/cen/coverstory/8148/8148counterpoint.html
H.F. Tibbals, Medical Nanotechnology and Nanomedicine (CRC Press, Boca Raton, 2010)
F. Hu, K.W. MacRenaris, E.A. Waters, E.A. Schultz-Sikma, A.L. Eckermann, T.J. Meade, Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem. Commun. Camb. 46(1), 73–75 (2010). doi:10.1039/b916562b
R.M. Shah, N.A. Shah, M.M. Del Rosario Lim, C. Hsieh, G. Nuber, S.I. Stupp, Supramolecular design of self-assembling nanofibers for cartilage regeneration. Proc. Natl. Acad. Sci. 107(8), 3293–3298 (2010)
V.M. Tysseling-Mattiace, V. Sahni, K.L. Niece, D. Birch, C. Czeisler, M.G. Fehlings, S.I. Stupp, J.A. Kessler, Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 28(14), 3814–3823 (2008)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer Science+Business B.V.
About this chapter
Cite this chapter
Mirkin, C.A., Nel, A., Thaxton, C.S. (2011). Applications: Nanobiosystems, Medicine, and Health. In: Nanotechnology Research Directions for Societal Needs in 2020. Science Policy Reports, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1168-6_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-1168-6_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1167-9
Online ISBN: 978-94-007-1168-6
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)